The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nuclear Medicine Market Research Report 2024
Synopsis
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Nuclear Medicine market was valued at US$ 6189.2 million in 2023 and is anticipated to reach US$ 10260 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
Report Scope
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Segment by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Nuclear Medicine market was valued at US$ 6189.2 million in 2023 and is anticipated to reach US$ 10260 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
Report Scope
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Segment by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2019-2030)
2.2 Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nuclear Medicine Historic Market Size by Region (2019-2024)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2025-2030)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2019-2024)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2023
3.5 Nuclear Medicine Key Players Head office and Area Served
3.6 Key Players Nuclear Medicine Product Solution and Service
3.7 Date of Enter into Nuclear Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2019-2024)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2025-2030)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2019-2024)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nuclear Medicine Market Size (2019-2030)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nuclear Medicine Market Size by Country (2019-2024)
6.4 North America Nuclear Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2019-2030)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nuclear Medicine Market Size by Country (2019-2024)
7.4 Europe Nuclear Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2019-2030)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2019-2030)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nuclear Medicine Market Size by Country (2019-2024)
9.4 Latin America Nuclear Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2019-2030)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Medicine Introduction
11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Detail
11.2.2 Bracco Imaging Business Overview
11.2.3 Bracco Imaging Nuclear Medicine Introduction
11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2019-2024)
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Detail
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Nuclear Medicine Introduction
11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2019-2024)
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Detail
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2019-2024)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Nuclear Medicine Introduction
11.5.4 Bayer Revenue in Nuclear Medicine Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Detail
11.6.2 Triad Isotopes Business Overview
11.6.3 Triad Isotopes Nuclear Medicine Introduction
11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2019-2024)
11.6.5 Triad Isotopes Recent Development
11.7 Nordion
11.7.1 Nordion Company Detail
11.7.2 Nordion Business Overview
11.7.3 Nordion Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Nuclear Medicine Business (2019-2024)
11.7.5 Nordion Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Detail
11.8.2 Jubilant Pharma Business Overview
11.8.3 Jubilant Pharma Nuclear Medicine Introduction
11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2019-2024)
11.8.5 Jubilant Pharma Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Nuclear Medicine Introduction
11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Detail
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Nuclear Medicine Introduction
11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2019-2024)
11.10.5 SIEMENS Recent Development
11.11 China Isotope & Radiation
11.11.1 China Isotope & Radiation Company Detail
11.11.2 China Isotope & Radiation Business Overview
11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2019-2024)
11.11.5 China Isotope & Radiation Recent Development
11.12 Dongcheng
11.12.1 Dongcheng Company Detail
11.12.2 Dongcheng Business Overview
11.12.3 Dongcheng Nuclear Medicine Introduction
11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2019-2024)
11.12.5 Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
